AKSO Announces Publication of Preclinical Data Demonstrating Engineered Soluble BCMA Decoy Receptor AB001 Effectively Inhibits Multiple Myeloma and Diffuse Large B Cell Lymphoma
- AB001 is an engineered high-affinity soluble BCMA decoy receptor that traps APRIL and BAFF,…